Topic: September quarter sequential growth vs. seasonal; macro recovery vs. peers
Key points:
September quarter guidance of +5.1% sequential is “well above seasonal” (normal seasonal ~3% per quarter).
December quarter is normally the weakest (slightly down sequentially); March quarter usually up.
Mgmt expects to continue above seasonal in December and March.
Tariff pull-in impact estimated at only mid- to high single-digits ($7M–$9M), based on forensic distributor analysis; no direct customers cited tariffs.
Microchip’s steeper decline vs. peers was due to PSP program (noncancelable orders continued longer); recovery driven by inventory digestion, not tariffs.
Mgmt stance: Bullish. Recovery is real and tied to Microchip-specific inventory dynamics, with negligible tariff distortion.
Q2 — Harsh V. Kumar
Topic: End-market growth (auto vs. ex-defense industrial); distributor sell-through vs. sell-in gap; inventory progress
Key points:
June quarter growth of +10.8% sequential was broad-based across all product lines, end markets, and geographies.
Sell-through at distribution was $49.3M higher than sell-in in June (vs. $103M gap in prior quarter); gap is shrinking but still exists.
Distribution is a bit less than 50% of total business; direct customers also draining inventory (no real-time data).
Inventory days dropped from 266 (Dec) → 251 (Mar) → 214 (Jun); target to break 200 by September (195–200).
Inventory reduced by $124.4M in June quarter; fabs running well below consumption; wafer starts will begin growing in December quarter to avoid a 30%–40% single-quarter spike.
Mgmt stance: Bullish. Strong inventory normalization progress; gap closing, but expects “a couple more quarters” to fully close.
Q3 — Christopher Caso
Topic: Confidence in inventory correction depth; direct vs. distributor inventory levels
Key points:
Exact inventory levels at customers are not “audit-proof”; customer base of 110,000+ makes precise analysis difficult.
Direct customers received more product during COVID (prioritized over distributors), so direct customer inventory is “probably higher” than distributor inventory.
Anecdotal evidence: some line items see buying return, others still not buying; correction will continue “for some time.”
Mgmt cannot put a high-confidence number on when normalization ends.
Mgmt stance: Neutral. Clear progress but lacks precision; inventory correction still ongoing and duration uncertain.
Q4 — Blayne Peter Curtis
Topic: Lead times; July bookings vs. turns requirement
Key points:
Most product lead times at 4–8 weeks; certain pockets extending to 6–10 weeks and some heading to 8–12 weeks due to shortages in lead frames/substrates or subcontractor capacity.
July bookings were the largest for any month in the last 3 years.
Backlog at start of September quarter is stronger than June quarter; turns requirement is about the same as last quarter.
Mgmt stance: Bullish. Extending lead times is a “warning shot” to customers to place healthier backlog; strong bookings and steady turns point to a good quarter.
Q5 — James Edward Schneider
Topic: Lagging end markets (automotive); tariff exemption interpretation from Trump’s press conference
Key points:
Automotive is the most lagging end market; AI data centers are recovering well; industrial small/medium customers are starting to recover.
“Other” revenue (non-MCU/non-analog, including licensing) is lumpy and was down slightly sequentially.
Mgmt’s interpretation of Trump tariff exemption: company qualifies based on large U.S. manufacturing investments and U.S. wafer production; may be in better shape than Japanese competitors.
Mgmt cautions that Trump statements are “never clear and often changes.”
Mgmt stance: Neutral-to-cautious on automotive lag; cautiously optimistic on tariff exemption but acknowledges uncertainty.
Topic: Incremental gross margins and competitive positioning in MCUs
Key points:
CFO Eric Bjornholt stated incremental gross margin for December quarter will be "roughly in that same ballpark" as June quarter (76%).
Fall-through to operating profit expected in a similar range.
CEO Steve Sanghi noted MCHP grew MCU revenue "double digits" sequentially in June quarter vs. industry up ~6%–6.5%, implying share gain.
MCHP is developing low-end 32-bit MCU parts; first introduction targeted "nearly the start of the next calendar year."
MCHP has enabled all 32-bit products to run on industry-standard tools (previously proprietary); also developed AI coding assistance tool that saves "almost 40% time for development."
Mgmt stance: Neutral — share loss from PSP strategy acknowledged, but recent share gain and product/tool improvements seen as positive; full recovery will take time.
Q12 — Tore Egil Svanberg
Topic: Utilization charges trajectory and cash flow priorities
Key points:
CEO Sanghi: utilization will improve "well before" inventory reaches 130–150 days target; "substantial improvement" expected in December quarter and continuing each quarter after.
CFO Bjornholt: MCHP borrowed ~$350 million to cover dividends in recent quarters; next $350 million of excess cash flow will repay that debt.
Current leverage is 4.2x; target leverage is 1.5x or lower for investment-grade rating.
Sanghi: "I wouldn't look for a stock buyback in the near term."
Mgmt stance: Cautious — debt repayment and leverage reduction prioritized over buybacks; utilization improvement is gradual.
Q13 — Vijay Raghavan Rakesh
Topic: Inventory write-downs, underutilization, and Section 232 tariff exemptions
Key points:
CFO Bjornholt: inventory write-downs will take "longer than" September quarter to complete; charge dropped from $90M to $77M last quarter, expected to be lower this quarter and continue declining.
Underutilization charges will decline "modestly" this quarter, then take "another step function down" in December quarter when wafer starts increase.
CEO Sanghi on Section 232: MCHP produces a "higher percentage" of product in U.S. than some peers (e.g., STMicro, Infineon), but rules are unclear; "I hope we have an advantage, but I'm not sure."
Topic: Seasonality, December/March guidance, and AI-related product revenue
Key points:
CFO Bjornholt: typical December seasonality is "down a couple percent"; March seasonality is "up a couple percent."
CEO Sanghi: expects business to be "better than seasonal" in both December and March quarters, but no specific guidance provided.
On AI products: no revenue breakdown given; AI coding tool launched in February, used internally for over a year, reported ~40% productivity improvement for customers.
AI-related FPGA uptick seen in vision/detection systems for factories; no data center product revenue disclosed.
Mgmt stance: Bullish on business trend (better than seasonal), but cautious on providing quantitative guidance; AI product revenue not broken out.
Q15 — Janet Ramkissoon
Topic: FX impact and China business trends
Key points:
CFO Bjornholt: foreign currency fluctuations have "smaller" impact on MCHP vs. European competitors; 99%+ of revenue is in U.S. dollars, most assets are U.S. dollar-based.
CEO Sanghi: China business "very strong"; revenue up ~14% sequentially from March (Chinese New Year) to June quarter.
Tariff concerns dominate agenda but "not really having impact today."
Mgmt stance: Neutral — FX risk minimal; China business strong near-term, but tariff uncertainty remains.